MedTrace Logo

Improving Patient Reported Outcome Measures in Catheter Ablation

NCT04499326 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-03-02

No results posted yet for this study

Summary

This study will assess whether more frequent measurement of patient reported outcome measures (PROMs) - specifically health related quality of life (HRQL) - can improve the evaluation of the clinical effectiveness and cost-effectiveness of catheter ablation of ventricular tachycardia (VT) in patients with an Implantable Cardioverter Defibrillator (ICD).

It is designed to have feasibility outcomes which contribute to answering the above.

Conditions

  • Ventricular Tachycardia
  • ICD
  • Quality of Life

Interventions

OTHER

Validated quality of life questionnaire (EQ-5D & C-CAP)

Patient quality of life to be assessed at baseline, 1, 2, 3, 4, 6, 9 and 12 months

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Pier Lambiase, PhD · UCL

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-13
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04499326 on ClinicalTrials.gov